Share on LinkedInShare on LinkedIn

ARTICLE · 09 DECEMBER 2021

Combating COVID-19 Or Generating Profits: What's More Crucial?

The COVID-19 pandemic, which was first identified in Wuhan, China in the month of December 2019, is not over yet as the war against the virus is still persistent.

IndiaIntellectual Property

Introduction

The COVID-19 pandemic, which was first identified in Wuhan, China in the month of December 2019, is not over yet as the war against the virus is still persistent. While some common population were struggling with their daily needs and were busy fighting over the limited stocks of Dettol hand sanitizers, the scientists of the world came up with various vaccines to fight the virus owing to their extensive research and experiments. However, most of the nations could not afford the resources to make a vaccine let alone manufacturing billions of vaccines for the masses. Unlike USA, not every nation has the power, potential or resources to declare themselves as a hegemony, right? That was the very reason that India and South Africa came up with a proposal known as the 'TRIPS waiver' in October 2020. Before digging deeper into this issue, one should know what exactly is a TRIPS waiver and how it is relevant to the COVID vaccine? Let's dig deeper!

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from